Organon & Co.
OGN
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio consists of three immunology products, such as Brenzysā¦ read more
Healthcare
Drug ManufacturersāGeneral
3 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$9.28
Price-1.70%
-$0.16
1Y
Price
Market Cap
$2.412b
Mid
Price/Earnings 3y Avg5y Avg
3.5x
Premium
Premium
Financials Overview
Key metrics over the past few years+29.5%
EBITDA Margin+12.4%
Net Profit Margin+1.9%
Free Cash Flow MarginRevenue
$4.689b
+1.3%
1y CAGR+0.2%
3y CAGR-5.3%
5y CAGREarnings
$555.145m
+2.4%
1y CAGR-6.1%
3y CAGR-13.9%
5y CAGREPS
$2.69
+2.5%
1y CAGR-6.3%
3y CAGR-14.1%
5y CAGRBook Value
$733m
$13.500b
Assets$12.767b
Liabilities$8.896b
DebtDebt to Assets
65.9%
5.9x
Debt to EBITDAFree Cash Flow
$323.224m
-5.6%
1y CAGR-19.6%
3y CAGR-13.9%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company